BioPort (Acquired by Emergent BioSolutions)

6 articles about BioPort (Acquired by Emergent BioSolutions)

• Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency

  1/31/2020

  A positive opinion for the approval of the company’s single-dose oral cholera vaccine, Vaxchora ® (Cholera Vaccine, Live, Oral).

• BioPortUSA Launches Novel Commercialization Accelerator for Foreign-Based Life Sciences Companies Entering the U.S. Market

  5/7/2007

• HHS Buys Additional AVA Anthrax Vaccine

  5/5/2006

• Mich. Firm To Provide Anthrax Vaccine

  5/9/2005

• Anthrax Vaccine Maker Announces Md. Facility

  12/1/2004

• War-Room Tactics Elicit Plan To Combat Bio-Terrorism

  9/30/2004